BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2014
View Archived Issues
Alzheimer's disease organizations fund drug repurposing studies
Read More
Scientists at M2i Development disclose novel diagnostic agents
Read More
Array BioPharma grants Oncothyreon exclusive license to ONT-380
Read More
Galapagos selects GLPG-2222 as part of its triple combination therapy for cystic fibrosis
Read More
Alnylam initiates phase III trial of revusiran in transthyretin-mediated amyloidotic cardiomyopathy
Read More
Novel JAK2 inhibitor NVP-CHZ868 displays potent activity in vitro and in murine MPN models
Read More
Hutchison MediPharma initiates phase III trial of fruquintinib in colorectal cancer
Read More
Inhibition of EZH2 leads to tumor growth inhibition in B-cell lymphoma cell lines
Read More
Study describes levels of biomarker of brain insulin resistance in hippocampal regions
Read More
Animal model of osteochondromagenesis highlights role of NFATc1
Read More
Kolltan Pharmaceuticals describes anti-SCFR monoclonal antibody
Read More
Antitumor activity seen with HER2-T-cell-dependent bispecific antibody developed at Genentech
Read More
BioCryst begins phase I trial of BCX-4430 for hemorrhagic fever viruses
Read More
Synageva BioPharma confirms active IND application for SBC-103
Read More
Novel CXCR-7 modulators disclosed by Actelion Pharmaceuticals
Read More
Cephalon divulges novel ALK inhibitors for cancer
Read More
Taiho Pharmaceutical patents novel compounds for urinary incontinence
Read More
Teijin Pharma reports new XO inhibitors
Read More
New company BliNK Biomedical created to focus on antibody discovery
Read More
Anthera Pharmaceuticals licenses Japanese rights to blisibimod to Zenyaku Kogyo
Read More
New study evaluates dabigatran etexilate to prevent recurrent embolic stroke of undetermined source
Read More
NEOD-001 given FDA fast track designation for AL amyloidosis
Read More
IND accepted for ADXS-HPV plus MEDI-4736 in HPV-associated cancers
Read More
Neovacs' phase IIb trial of TNF-Kinoid in rheumatoid arthritis misses endpoint
Read More
FDA approves Signifor LAR for acromegaly
Read More
ViiV Healthcare applies for Japanese approval of dolutegravir/abacavir/lamivudine
Read More